Vitamin E and cancer
- PMID: 17628185
- DOI: 10.1016/S0083-6729(07)76017-X
Vitamin E and cancer
Abstract
Perhaps not surprisingly, vitamin E which has been touted to be potentially beneficial for a variety of disorders, including cancer, heart disease, and even Alzheimer's disorder, based on its function as an antioxidant has failed to withstand the scrutiny of recent, double-blinded, placebo-controlled clinical trials, including failure to provide science-based support for vitamin E as a potent anticancer agent. Although less studied, vitamin E forms other than RRR-alpha-tocopherol or synthetic all-rac-alpha-tocopherol show promise as anticancer agents in preclinical studies. This chapter will (1) review basic information about natural and synthetic vitamin E compounds as well as vitamin E analogues, (2) summarize the current status of human intervention trials, (3) review data from preclinical cell culture and animal model studies of vitamin E compounds and novel vitamin E-based analogues in regards to future potential for cancer treatment, and (4) summarize some of the insights that have been gained into the anticancer mechanisms of action of vitamin E-based compounds which are providing interesting insights into their potent proapoptotic effects, which include restoration of apoptotic signaling pathways and blockage of prosurvival signaling events.
Similar articles
-
Vitamin E and apoptosis.Vitam Horm. 2007;76:329-56. doi: 10.1016/S0083-6729(07)76012-0. Vitam Horm. 2007. PMID: 17628180 Review.
-
Vitamin E analogues as anticancer agents: lessons from studies with alpha-tocopheryl succinate.Mol Nutr Food Res. 2006 Aug;50(8):675-85. doi: 10.1002/mnfr.200500267. Mol Nutr Food Res. 2006. PMID: 16835868 Review.
-
In vitro and in vivo evaluation of anticancer actions of natural and synthetic vitamin E forms.Mol Nutr Food Res. 2008 Apr;52(4):447-56. doi: 10.1002/mnfr.200700254. Mol Nutr Food Res. 2008. PMID: 18381678
-
Vitamin E supplementation in cardiovascular disease and cancer prevention: Part 1.Ann Pharmacother. 2005 Nov;39(11):1870-8. doi: 10.1345/aph.1G211. Epub 2005 Sep 27. Ann Pharmacother. 2005. PMID: 16189282 Review.
-
Dietary administration of the proapoptotic vitamin E analogue alpha-tocopheryloxyacetic acid inhibits metastatic murine breast cancer.Cancer Res. 2006 Oct 1;66(19):9374-8. doi: 10.1158/0008-5472.CAN-06-2403. Cancer Res. 2006. PMID: 17018590
Cited by
-
Vitamin E δ-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells.Sci Rep. 2016 Jul 27;6:30502. doi: 10.1038/srep30502. Sci Rep. 2016. PMID: 27461002 Free PMC article.
-
Vitamin E Supplement Protects Against Gestational Diabetes Mellitus in Mice Through nuclear factor-erythroid factor 2-related factor 2/heme oxygenase-1 Signaling Pathway.Diabetes Metab Syndr Obes. 2023 Mar 1;16:565-574. doi: 10.2147/DMSO.S397255. eCollection 2023. Diabetes Metab Syndr Obes. 2023. PMID: 36883138 Free PMC article.
-
Targeting cholesterol-rich microdomains to circumvent tamoxifen-resistant breast cancer.Breast Cancer Res. 2011;13(6):R120. doi: 10.1186/bcr3063. Epub 2011 Nov 24. Breast Cancer Res. 2011. PMID: 22115051 Free PMC article.
-
Microalgal Derivatives as Potential Nutraceutical and Food Supplements for Human Health: A Focus on Cancer Prevention and Interception.Nutrients. 2019 May 29;11(6):1226. doi: 10.3390/nu11061226. Nutrients. 2019. PMID: 31146462 Free PMC article. Review.
-
δ-Tocotrienol and quercetin reduce serum levels of nitric oxide and lipid parameters in female chickens.Lipids Health Dis. 2011 Feb 28;10:39. doi: 10.1186/1476-511X-10-39. Lipids Health Dis. 2011. PMID: 21356098 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous